Pachyonychia Congenita: A Research Agenda Leading to New Therapeutic Approaches.

Pachyonychia Congenita: A Research Agenda Leading to New Therapeutic Approaches.

O'Toole E,Kelsell D,Caterina M,de Brito M,Hansen D,Hickerson R,Hovnanian A,Kaspar R,Lane E,Paller A,Schwartz J,Shroot B,Teng J,Titeux M,Coulombe P,Sprecher E

Source :

2023 Déc 15

Pmid / DOI:

38099888

Abstract

Pachyonychia congenita (PC) is a dominantly inherited genetic disorder of cornification. PC stands out among other genodermatoses because despite its rarity, it has been the focus of a very large number of pioneering translational research efforts over the past 2 decades, mostly driven by a patient support organization, the Pachyonychia Congenita Project. These efforts have laid the ground for innovative strategies that may broadly impact approaches to the management of other inherited cutaneous and noncutaneous diseases. This article outlines current avenues of research in PC, expected outcomes, and potential hurdles.KEYWORDSDrug repurposing, Genodermatosis, Keratoderma, Nails, Pachyonychia congenitaCopyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.

Voir la publication

Toutes les publications